Market Tracker

03/27 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

118.83
Delayed Data
As of 3:59pm ET
 -0.43 / -0.36%
Today’s Change
109.12
Today|||52-Week Range
162.00
-2.88%
Year-to-Date

Today’s Trading

Previous close119.26
Today’s open117.83
Day’s range115.58 - 119.05
Volume2,400,393
Average volume (3 months)2,498,914
Market cap$26.8B
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+12.94%
Earnings growth (next 5 years)+23.70%
Revenue growth (last year)+21.11%
P/E ratio67.5
Price/Sales9.22
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.12+0.22%
BAXBaxter International...-0.19-0.37%
INCYIncyte Corp+0.25+0.18%
VRTXVertex Pharmaceutica...+0.82+0.91%
Data as of 4:14pm ET, 03/27/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.24
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David Richard Brennan
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts